Literature DB >> 11725354

Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas.

H Kaya1, E Kotiloğlu, S Inanli, G Ekicioğlu, S U Bozkurt, A Tutkun, S Küllü.   

Abstract

In this retrospective study, we investigated the HPV DNA occurrence in 21 laryngeal and 26 primary lung squamous cell carcinomas. Nonisotopic in situ hybridization (NISH) technique was performed with commercially available digoxigenin-labelled DNA probes for HPV screening. Subtyping for HPV subtypes 6/11, 16/18 and 31/33 was also performed. We observed HPV DNA signals in 10 (47.6%) cases of laryngeal SCC and in only 3 (11.5%) cases of lung SCC. Typing showed signals of HPV 6/11, 16/18 and 31/33 infection in 80%, 40%, 30% of the laryngeal carcinomas, respectively. In the lung, we demonstrated type 16/18 positivity in two and type 6/11 in one of the HPV-positive cases. We found a statistically significant correlation between HPV infection and tumour recurrence (p < 0.035) in laryngeal carcinomas, but not between HPV presence and tumour stage or grade in neither larynx nor lung.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725354

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  12 in total

Review 1.  HPV infections and lung cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

3.  Could human papillomaviruses be spread through blood?

Authors:  Sohrab Bodaghi; Lauren V Wood; Gregg Roby; Celia Ryder; Seth M Steinberg; Zhi-Ming Zheng
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Colorectal papillomavirus infection in patients with colorectal cancer.

Authors:  Sohrab Bodaghi; Koji Yamanegi; Shu-Yuan Xiao; Maria Da Costa; Joel M Palefsky; Zhi-Ming Zheng
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 5.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth.

Authors:  Ignacio G Bravo; Angel Alonso
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis.

Authors:  Malini Srinivasan; Emanuela Taioli; Camille C Ragin
Journal:  Carcinogenesis       Date:  2009-07-20       Impact factor: 4.944

8.  HPV in exhaled breath condensate of lung cancer patients.

Authors:  G E Carpagnano; A Koutelou; M I Natalicchio; D Martinelli; C Ruggieri; A Di Taranto; R Antonetti; F Carpagnano; M P Foschino-Barbaro
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

Review 9.  High-Risk HPVs and Human Carcinomas in the Syrian Population.

Authors:  Ala-Eddin Al Moustafa; Lina Ghabreau; Nizar Akil; Samer Rastam; Amal Alachkar; Amber Yasmeen
Journal:  Front Oncol       Date:  2014-04-02       Impact factor: 6.244

10.  Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region.

Authors:  Santiago García-Vallvé; José R Iglesias-Rozas; Angel Alonso; Ignacio G Bravo
Journal:  BMC Evol Biol       Date:  2006-03-09       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.